# Effect of NGX-4010 on ENFD and Sensory Function

> **NCT00254449** · PHASE1 · COMPLETED · sponsor: **NeurogesX** · enrollment: 36 (—)

## Conditions studied

- Human Volunteers

## Interventions

- **DRUG:** NGX-4010

## Key facts

- **NCT ID:** NCT00254449
- **Lead sponsor:** NeurogesX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 36 (—)
- **Last updated:** 2009-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254449, "Effect of NGX-4010 on ENFD and Sensory Function". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00254449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*